Vazkepa
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Vazkepa, covering 2026-03-13 to 2026-03-13. Get the full timeline:
Most recent: EMA Authorised: Vazkepa (Icosapent ethyl) — Recordati Industria Chimica e Farmaceutica S.p.A.